Cohort study2017Open access

Prospective Study of Nut Consumption and Incidence of Metabolic Syndrome: Tehran Lipid and Glucose Study

Hosseinpour-Niazi S, Hosseini S, Mirmiran P, Azizi F

Nutrients · 32 citations

Review labels

Food frequency questionnaire

Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.

How it was studied

Design
Cohort study (indexed by PubMed)
Studied in
People
Main outcome
Clinical events such as disease or death
Intake measured by
Food frequency questionnaire

Who paid for it

Funding
Independent funding
Nonprofit
American Heart Association

Based on 1 listed funder(s) and full-text disclosure statement.

Publication

Published
2017-09-23 · Nutrients · vol. 9 · issue 10 · p. 1056
Publisher
Multidisciplinary Digital Publishing Institute
Cited
37 citations · more than 91% of similar papers · 2.9× the field average
Impact
Top 10% most cited in its field
References
46 works
Access
Open access (journal) · CC-BY
Research areas
Nuts composition and effects · Horticultural and Viticultural Research · Nutritional Studies and Diet
Keywords
Medicine, Nut, Metabolic syndrome, Odds ratio, Prospective cohort study, Confounding, Body mass index, Interquartile range, Refined grains, Incidence (geometry), Diabetes mellitus, Obesity, Population, Confidence interval, Internal medicine, Environmental health, Food science, Endocrinology, Whole grains, Biology
MeSH
humans, juglans, nuts, blood glucose, lipids, incidence, multivariate analysis, logistic models, odds ratio, risk factors, chi-square distribution, prospective studies, risk reduction behavior, time factors, adult, middle aged, iran, female, male, recommended dietary allowances, serving size, protective factors, biomarkers, metabolic syndrome, diet, healthy

4 authors

From IR

  • Somayeh Hosseinpour‐NiaziResearch Institute for Endocrine Sciences; Shahid Beheshti University of Medical Sciences
  • Shabnam HosseiniResearch Institute for Endocrine Sciences; Shahid Beheshti University of Medical Sciences
  • Parvin MirmiranNational Nutrition and Food Technology Research Institute; Shahid Beheshti University of Medical Sciences
  • Fereidoun AziziResearch Institute for Endocrine Sciences; Shahid Beheshti University of Medical Sciences

Abstract

This study aimed to assess the association of various types of nut per se, and total nut consumption with the incidence of metabolic syndrome (MetS). A 6.2 ± 0.7-year population-based prospective study was conducted among 1265 adults, aged 19-74 years, participants of the Tehran Lipid and Glucose Study. A 168-item semi-quantitative food frequency questionnaire was used to collect information on nut consumption. MetS was defined according to the Joint Interim Statement guidelines and 276 new cases of MetS were identified. Median ± interquartile range of nut consumption was 2.08 (0.88-5.68) servings/week. After adjusting for family history of diabetes, age, gender, smoking, physical activity, fasting serum glucose at baseline, serum high density lipoprotein cholesterol (HDL-C) at baseline, energy intake, fiber, macronutrients, cholesterol intake, fruit, vegetables, dairy products and body mass index (BMI), a statistically significant decrease was observed in MetS in the third (≥5 servings/week) tertile of nuts (odds ratio: 0.68, 95% CI: 0.44-0.91, p trend: 0.03) compared with the lowest (≤1 serving/week). Walnut consumption showed a significant, inverse association with MetS risk; associations for other nut varieties were not significant. For each additional serving/week of walnuts consumed, incidence of MetS decreased by 3% (ORs: 0.97 CI: 0.93-0.99), after adjusting for confounding factors. Total nut consumption, especially walnuts, reduces the risk of MetS.

Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY).

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.